Agios Pharmaceuticals | AGIO - Capital Ordinaire





Capital Ordinaire Changement Date
AbbVie USD 1.77B 608K 2026-06
Agios Pharmaceuticals USD 59.6M 264K 2026-06
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
Amgen USD 541M 0 2026-09
Arrowhead Research USD 141.14M 564K 2026-06
Astellas Pharma JPY 1.79B 109K 2026-09
AstraZeneca USD 1.55B 28K 2026-09
Bayer EUR 982.42M 0 2026-09
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Daiichi Sankyo JPY 1.82B 1.68M 2026-09
Eli Lilly USD 943.5M 3.33M 2026-03
Exelixis USD 244.68M 4.21M 2026-09
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Incyte USD 200.98M 1.03M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Merck USD 2.47B 1.05M 2026-06
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novartis USD 1.89B 12.09M 2026-09
Novartis USD 1.89B 19.47M 2026-09
Pfizer USD 5.7B 0 2026-06
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sarepta Therapeutics USD 107.23M 1.61M 2026-09
Vertex Pharmaceuticals USD 253.5M 200K 2026-09